Insulet’s (PODD) “Buy” Rating Reiterated at BTIG Research

Insulet’s (PODD) “Buy” Rating Reiterated at BTIG Research

BTIG Research reaffirmed their buy rating on shares of Insulet (NASDAQ:PODD – Free Report) in a research note released on Thursday morning,Benzinga reports. The firm currently has a $370.00 price target on the medical instruments supplier’s stock. Other equities analysts also recently issued research reports about the stock. Royal Bank Of Canada increased their price target on shares of Insulet from $365.00 to $370.00 and gave the company an “ou…

Riskified (NYSE:RSKD) Stock Price Expected to Rise, UBS Group Analyst Says

Riskified (NYSE:RSKD – Get Free Report) had its price objective increased by UBS Group from $5.00 to $5.50 in a research report issued to clients and investors on Thursday,Benzinga reports. The firm presently has a “neutral” rating on the stock. UBS Group’s price objective would suggest a potential upside of 22.77% from the company’s previous […]